The patient was discharged with alleviated jaundice and significantly improved liver function indexes after 1 month of symptomatic treatments. Maintenance treatments with oral UDCA (50 mg/day), compound glycyrrhizin (12.5 mg/day), and fat-soluble vitamins (vitamin AD, 1800 U/day; vitamin E, 25 mg/day) were recommended to be continued further after discharge from the hospital. During the recent 9-month follow-up period, he had complete clinical and biochemical recovery except for slightly elevated levels of AST and TBA (Table 1). At this writing, he is 1 year old and remains stable with a normal growth (weight, 8,750 g; height, 74 cm) after drug withdrawal for 3 months. He can walk with the help of an instrument, and no sign of bone fragility was observed. His language development is normal, and repeated hearing testing was unremarkable.